Back to top
more

Virtus Biotech Clinical Trials ETF: (BBC)

(Delayed Data from NYSE) As of Nov 20, 2026 03:59 PM ET

$38.17 USD

38.17
53,413

-1.60 (-4.02%)

Volume: 53,413

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

2 - Buy of 5   2      

After-Market: $38.55 +0.38 (1.00 %) 7:58 PM ET

Zacks News

Sweta Killa headshot

Biotech ETF (BBC) Hits a New 52-Week High

This biotech ETF hits a new 52-week high. Are more gains in store for this ETF?

Sanghamitra Saha headshot

Stocks & ETFs Beneficiaries of Coronavirus Vaccine Ramp-Up

Efforts in formulating a coronavirus vaccine are heating up. These stocks and ETFs look to be the largest beneficiaries.

Sanghamitra Saha headshot

Top ETF Areas of Last Week

Wall Street was upbeat last week, mainly driven by these ETF areas.

Sanghamitra Saha headshot

5 Market-Beating Smart-Beta ETF Charts of 2019

These smart-beta ETFs beat the broader market with ease in 2019.

Neena Mishra headshot

A Banner Year for Stocks

Major indexes are on track for their best annual performance in six years, powered by tech companies

Sanghamitra Saha headshot

Biotech Rally Sends Nasdaq to 9000: ETFs in Focus

Some biotech stocks have contributed materially to the Nasdaq's 1000-point gain since Aug 27, 2018 and helped it notch a record 9,000 on Dec 26.

Sweta Killa headshot

9 ETFs at the Forefront of 2019 Market Rally

As there have been winners in many corners of the space, we highlight nine ETFs from different zones that have outperformed so far this year. These are expected to continue outperforming, provided the fundamentals remain intact.

Sanghamitra Saha headshot

Best & Worst ETFs of Fourth Quarter

Inside the top and worst-performing ETFs of the fourth quarter.

Sanghamitra Saha headshot

4 Sector ETFs That Beat the Market in Q4

While Wall Street is surging this quarter, these sector ETFs offered even better performances to beat the market.

Sweta Killa headshot

Biotech Leading in Q4: Best ETFs & Stocks

We highlight five biotech ETFs and stocks that are leading the market in Q4.